174 related articles for article (PubMed ID: 25577253)
1. Prognostic significance of pretreatment VEGF, survivin, and Smac/DIABLO serum levels in patients with serous ovarian carcinoma.
Dobrzycka B; Mackowiak-Matejczyk B; Terlikowska KM; Kulesza-Bronczyk B; Kinalski M; Terlikowski SJ
Tumour Biol; 2015 Jun; 36(6):4157-65. PubMed ID: 25577253
[TBL] [Abstract][Full Text] [Related]
2. Low circulating serum levels of second mitochondria-derived activator of caspase (Smac/DIABLO) in patients with bladder cancer.
Mizutani Y; Katsuoka Y; Bonavida B
Int J Oncol; 2012 Apr; 40(4):1246-50. PubMed ID: 22218530
[TBL] [Abstract][Full Text] [Related]
3. Survivin interacts with Smac/DIABLO in ovarian carcinoma cells but is redundant in Smac-mediated apoptosis.
McNeish IA; Lopes R; Bell SJ; McKay TR; Fernandez M; Lockley M; Wheatley SP; Lemoine NR
Exp Cell Res; 2005 Jan; 302(1):69-82. PubMed ID: 15541727
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of Smac/DIABLO expression in renal cell carcinoma and its prognostic significance.
Mizutani Y; Nakanishi H; Yamamoto K; Li YN; Matsubara H; Mikami K; Okihara K; Kawauchi A; Bonavida B; Miki T
J Clin Oncol; 2005 Jan; 23(3):448-54. PubMed ID: 15572731
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of second mitochondria-derived activator of caspase (Smac/DIABLO) expression in bladder cancer and target for therapy.
Mizutani Y; Katsuoka Y; Bonavida B
Int J Oncol; 2010 Aug; 37(2):503-8. PubMed ID: 20596678
[TBL] [Abstract][Full Text] [Related]
6. Expression and prognostic significance of the inhibitor of apoptosis protein (IAP) family and its antagonists in chronic lymphocytic leukaemia.
Grzybowska-Izydorczyk O; Cebula B; Robak T; Smolewski P
Eur J Cancer; 2010 Mar; 46(4):800-10. PubMed ID: 20045309
[TBL] [Abstract][Full Text] [Related]
7. Clinical significance of Smac/DIABLO expression in colorectal cancer.
Endo K; Kohnoe S; Watanabe A; Tashiro H; Sakata H; Morita M; Kakeji Y; Maehara Y
Oncol Rep; 2009 Feb; 21(2):351-5. PubMed ID: 19148507
[TBL] [Abstract][Full Text] [Related]
8. Relationship between expression of Smac and Survivin and apoptosis of primary hepatocellular carcinoma.
Bao ST; Gui SQ; Lin MS
Hepatobiliary Pancreat Dis Int; 2006 Nov; 5(4):580-3. PubMed ID: 17085346
[TBL] [Abstract][Full Text] [Related]
9. Serum vascular endothelial growth factor in epithelial ovarian neoplasms: correlation with patient survival.
Chen CA; Cheng WF; Lee CN; Chen TM; Kung CC; Hsieh FJ; Hsieh CY
Gynecol Oncol; 1999 Aug; 74(2):235-40. PubMed ID: 10419737
[TBL] [Abstract][Full Text] [Related]
10. Direct interaction between survivin and Smac/DIABLO is essential for the anti-apoptotic activity of survivin during taxol-induced apoptosis.
Song Z; Yao X; Wu M
J Biol Chem; 2003 Jun; 278(25):23130-40. PubMed ID: 12660240
[TBL] [Abstract][Full Text] [Related]
11. Expression levels of the mitochondrial IAP antagonists Smac/DIABLO and Omi/HtrA2 in clear-cell renal cell carcinomas and their prognostic value.
Kempkensteffen C; Hinz S; Christoph F; Krause H; Magheli A; Schrader M; Schostak M; Miller K; Weikert S
J Cancer Res Clin Oncol; 2008 May; 134(5):543-50. PubMed ID: 17922292
[TBL] [Abstract][Full Text] [Related]
12. Transfection of Smac/DIABLO sensitizes drug-resistant tumor cells to TRAIL or paclitaxel-induced apoptosis in vitro.
Mao HL; Liu PS; Zheng JF; Zhang PH; Zhou LG; Xin G; Liu C
Pharmacol Res; 2007 Dec; 56(6):483-92. PubMed ID: 18029193
[TBL] [Abstract][Full Text] [Related]
13. Smac/DIABLO expression in human gastrointestinal carcinoma: Association with clinicopathological parameters and survivin expression.
Shintani M; Sangawa A; Yamao N; Kamoshida S
Oncol Lett; 2014 Dec; 8(6):2581-2586. PubMed ID: 25364431
[TBL] [Abstract][Full Text] [Related]
14. Nuclear interaction of Smac/DIABLO with Survivin at G2/M arrest prompts docetaxel-induced apoptosis in DU145 prostate cancer cells.
Kim JY; Chung JY; Lee SG; Kim YJ; Park JE; Yoo KS; Yoo YH; Park YC; Kim BG; Kim JM
Biochem Biophys Res Commun; 2006 Dec; 350(4):949-54. PubMed ID: 17045968
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of survivin, X-linked inhibitor of apoptosis protein and second mitochondria-derived activator of caspases expression in advanced non-small-cell lung cancer patients.
Chen P; Li J; Ge LP; Dai CH; Li XQ
Respirology; 2010 Apr; 15(3):501-9. PubMed ID: 20210890
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance of Smac and survivin expression in breast cancer patients treated with anthracycline‑based neoadjuvant chemotherapy.
Zhao YC; Wang Y; Ni XJ; Li Y; Wang XM; Zhu YY; Luo CY
Mol Med Rep; 2014 Feb; 9(2):614-20. PubMed ID: 24317109
[TBL] [Abstract][Full Text] [Related]
17. The clinical significance of the combined detection of serum Smac, HE4 and CA125 in endometriosis-associated ovarian cancer.
Xu XR; Wang X; Zhang H; Liu MY; Chen Q
Cancer Biomark; 2018 Feb; 21(2):471-477. PubMed ID: 29226858
[TBL] [Abstract][Full Text] [Related]
18. [Effect of antisurvivin oligodeoxynucleotides on proliferation and apoptosis in gastric cancer cell line BGC-823 and the molecular mechanism].
Li Y; Fan LQ; Sun Y; Zhao Q; Tan BB; Liu Y
Zhonghua Zhong Liu Za Zhi; 2011 Apr; 33(4):265-9. PubMed ID: 21575496
[TBL] [Abstract][Full Text] [Related]
19. Reciprocal expression of survivin and SMAC/DIABLO in primary breast cancer.
Mansour A; Nabil M; Ali-Labib R; Said H; Annos F
Med Oncol; 2012 Dec; 29(4):2535-42. PubMed ID: 22161156
[TBL] [Abstract][Full Text] [Related]
20. Activation of the PI3K/AKT pathway mediates FSH-stimulated VEGF expression in ovarian serous cystadenocarcinoma.
Huang Y; Hua K; Zhou X; Jin H; Chen X; Lu X; Yu Y; Zha X; Feng Y
Cell Res; 2008 Jul; 18(7):780-91. PubMed ID: 18574502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
